Coronavirus: Greek company donates chloroquine to Cyprus

A Greek pharmaceuticals company said Thursday it will be donating to Cyprus some 60,000 doses of the chloroquine-based drug Unikinon.

In a statement, Uni-Pharma SA said it would also distribute 24 million doses of the drug to all coronavirus reference hospitals in Greece.

The drug was approved for distribution by Greece’s National Organization for Medicines.

Uni-Pharma SA clarified that the purchase of fine tonnes for the active ingredient of Unikinon was a company initiative, and it paid for the expenditure entirely on its own.

A company statement on its site said that chloroquine, along with hydroxychloroquine, are being researched globally as a treatment for Covid-91, “but their effectiveness in curing Covid-19 remains under review through studies.”

The Cyprus Mail is the only English-language daily newspaper published in Cyprus. It was established in 1945 and today, with its popular and widely-read website, the Cyprus Mail is among the most trusted news sites in Cyprus. The newspaper is not affiliated with any political parties and has always striven to maintain its independence. Over the past 70-plus years, the Cyprus Mail, with a small dedicated team, has covered momentous events in Cyprus’ modern history, chronicling the last gasps of British colonial rule, Cyprus’ truncated independence, the coup and Turkish invasion, and the decades of negotiations to stitch the divided island back together, plus a myriad of scandals, murders, and human interests stories that capture the island and its -people. Observers describe it as politically conservative.